Skip to main content

Methylene Blue

Methylene blue (methylthioninium chloride) is a deep-blue visible-light dye with a century of surgical use. It is the workhorse dye for fistula localization, ureteral-orifice identification, and urethral-anastomotic integrity testing — none of which require specialized imaging hardware. Methylene blue is also a bona fide pharmacologic agent used to treat acquired methemoglobinemia, giving it a dual identity as dye and drug.[1]

Pharmacology​

PropertyValue
ClassThiazine dye; redox agent
Molecular formulaC₁₆H₁₈ClN₃S
ColorDeep blue (visible in daylight and ambient OR light)
Concentration (commercial)10 mg/mL injectable solution; 1% (10 mg/mL) oral solution
Renal excretionSignificant — appears in urine as blue-green color after IV dose
Biliary excretionMinor
FDA approvalMethemoglobinemia treatment (primary indication); off-label for surgical dye applications

Dual role — dye and drug​

  • As a dye: visualizes urinary leak, fistula tracts, ureteral orifices
  • As a drug: reverses methemoglobinemia (dose 1–2 mg/kg IV), used in some septic-shock research protocols
  • Serotonin syndrome risk: methylene blue is a potent MAO inhibitor — use cautiously in patients on serotonergic agents (SSRIs, SNRIs, MAO inhibitors); can precipitate serotonin syndrome at pharmacologic doses, less so at dye-sized doses

GU Reconstruction Applications​

1. Vesicovaginal and urethrovaginal fistula localization​

The most classic dye application. Bladder instillation identifies even small fistula tracts:[2]

"Three-swab test" (Dye test for occult VVF):

  1. Place three white swabs (gauze sponges) sequentially into the vagina: one high at the apex, one middle, one distal
  2. Instill 200–300 mL of dilute methylene blue (25 mg in 250 mL saline) into the bladder via Foley
  3. Ambulate the patient or have her cough and Valsalva
  4. Remove swabs and inspect:
    • Distal swab only blue → urethral leak or distal VVF
    • Apical swab blue → proximal VVF
    • No blue on any swab → consider ureterovaginal fistula (methylene blue doesn't reach ureter from IV because of MAO inhibition concerns; use intravenous indigo carmine historically, now often phenazopyridine by mouth for the "double-dye test")

Double-dye test:

  • Oral phenazopyridine (200 mg) colors urine orange (appears in ureteral urine, not bladder-instilled urine)
  • Methylene blue instilled into bladder colors bladder urine blue
  • Orange distal swab → ureterovaginal fistula (urine reached vagina from ureter)
  • Blue any swab → vesicovaginal fistula

2. Ureteral orifice identification (cystoscopic)​

  • Intravesical methylene blue (5–10 mL of 10 mg/mL diluted in 50 mL saline) used to darken bladder mucosa → improves contrast for identifying ureteral orifices
  • Direct injection into the distal ureter via ureteral catheter confirms orifice identification
  • Particularly useful in edematous or inflamed bladders (radiation, chronic cystitis, recent instrumentation) where normal orifice landmarks are obscured

3. Urethral anastomotic integrity testing​

  • After urethral reconstruction (urethroplasty, vesicourethral anastomosis after radical prostatectomy), bladder is filled with dilute methylene blue via Foley
  • Visual leak test — any extravasation at the anastomotic line is directly visible
  • Gold-standard intraoperative leak test for urethroplasty anastomoses
  • See knotless barbed sutures for anastomosis

4. Lymphatic mapping (pre-ICG era)​

  • Historically used for sentinel node identification in breast, melanoma, and penile cancer
  • Largely replaced by ICG in centers with NIR imaging, though remains useful in resource-limited settings or in sentinel-node mapping without NIR hardware

5. Intraoperative methylene blue as adjunct (rare)​

  • Parathyroid surgery (outside scope) — historical use
  • Neurosurgery — intraventricular dye
  • Genital mucosa mapping — vulvar lesion mapping in gynecology

Dosing​

For dye applications​

  • VVF "three-swab" test: 25 mg in 250 mL saline intravesical
  • Ureteral orifice identification: 5–10 mL of 10 mg/mL diluted in 50 mL saline intravesical; or 1–2 mL injected directly via ureteral catheter
  • Urethral anastomosis leak test: 50–100 mL of dilute solution (25 mg in 250 mL saline) intravesical
  • Lymphatic mapping: 1–2 mL of 1% solution injected peritumorally or intradermally

For methemoglobinemia treatment (pharmacologic)​

  • 1–2 mg/kg IV over 5 minutes
  • Repeat dose at 1 hour if persistent methemoglobinemia

Contraindications and Cautions​

  • G6PD deficiency — methylene blue is contraindicated at pharmacologic doses (precipitates hemolysis); dye doses may still be used with caution
  • Serotonergic medications — SSRIs, SNRIs, MAO inhibitors, triptans → risk of serotonin syndrome with pharmacologic dosing. Dye-sized doses carry much lower risk but warrant awareness
  • Iodine allergy — not a contraindication (methylene blue contains no iodine, unlike ICG)
  • Pregnancy — limited data; avoid IV at pharmacologic doses
  • Neonates — risk of hemolysis; avoid IV dosing

Adverse Events​

  • Blue-green urine — expected, resolves in 12–24 hours
  • Blue discoloration of skin, tongue, conjunctivae — temporary
  • Nausea, vomiting — rare at dye doses
  • Serotonin syndrome — documented at pharmacologic doses in patients on serotonergic agents
  • Hemolysis — in G6PD-deficient patients
  • False elevation of SpO₂ on pulse oximetry — transient (methylene blue absorbs light at pulse-ox wavelengths)

Practical Pearls​

  • Dilute before use — straight 10 mg/mL is too concentrated for most dye applications; dilute to avoid staining everything in the field
  • Warn the anesthesiologist — transient SpO₂ drop on pulse oximetry after IV methylene blue is not true desaturation
  • Coordinate with pharmacy — methylene blue is an old and cheap drug but occasionally in short supply
  • Have it on the field before you need it — VVF dye tests can't be improvised
  • Do not inject into the urinary tract if you plan to follow with ICG perfusion assessment — the visible blue staining can obscure white-light fields

Methylene Blue vs. Indigo Carmine vs. Pudexacianinium​

FeatureMethylene blueIndigo carminePudexacianinium
ClassVisible dyeVisible dyeNIR fluorophore
Primary useFistula / intra-luminalUreter (IV) — historicalUreter (IV NIR) — modern
Imaging requiredNone (visible)None (visible)NIR system required
AvailabilityConsistentIntermittent shortages since 2014New; ramping
CostVery lowLowHigh
GU nicheFistula, orifice ID, anastomotic leakObsolescentUreter ID in MIS

See Also​

References​

1. Ginimuge PR, Jyothi SD. Methylene blue: revisited. J Anaesthesiol Clin Pharmacol. 2010;26(4):517–20.

2. Hilton P. Urogenital fistula in the UK: a personal case series managed over 25 years. BJU Int. 2012;110(1):102–10. doi:10.1111/j.1464-410X.2011.10630.x